Singular Genomics is a life science technology company that develops multiomic technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X Spatial Sequencer, which leverages Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in FFPE tissue, with spatial context and on the same platform as the G4. The G4X retains the NGS Sequencing capabilities of the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.